Myriad Genetics (MYGN) Consolidated Net Income (2009 - 2026)
Myriad Genetics (MYGN) posted quarterly Consolidated Net Income of -$34.1 million for Q1 2026, down 34000.0% year-over-year from N/an in Q1 2025, and down 331.65% quarter-over-quarter from -$7.9 million in Q4 2025.
Myriad Genetics (MYGN) Consolidated Net Income (2009 - 2026) Analysis & Trends
Myriad Genetics (MYGN) has reported Consolidated Net Income for 18 consecutive years, with -$34.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Consolidated Net Income fell 34000.0% year-over-year to -$34.1 million; the TTM figure through Mar 2026 stood at -$399.9 million (down 294.38% YoY), while the FY2025 annual figure was -$365.9 million, down 187.43% from the prior year.
- Consolidated Net Income retreated to -$34.1 million in Q1 2026 per MYGN's latest filing, from -$7.9 million in the prior quarter.
- Across five years, Consolidated Net Income topped out at -$100000.0 in Q1 2025 and bottomed at -$330.5 million in Q2 2025.
- Historically, Consolidated Net Income has averaged -$53.1 million across 5 years, with a median of -$34.1 million in 2026.
- Annual changes were most pronounced in 2025 — Consolidated Net Income surged 99.62% — and 2026, when it plunged 34000.0%.
- Myriad Genetics' Consolidated Net Income stood at -$42.3 million in 2022, then gained by 26.24% to -$31.2 million in 2023, then plunged by 36.22% to -$42.5 million in 2024, then jumped by 81.41% to -$7.9 million in 2025, then slumped by 331.65% to -$34.1 million in 2026.
- Business Quant data shows MYGN's Consolidated Net Income at -$34.1 million in Q1 2026, -$7.9 million in Q4 2025, and -$27.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.99 Bn | 209.92 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 140.41 Bn | 136.06 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Idexx Laboratories | 46.27 Bn | 46.08 Bn | 779.09 Mn | 338.41 Mn |
| 4 | Agilent Technologies | 39.81 Bn | 38.00 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 39.53 Bn | 37.45 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Natera | 38.83 Bn | 37.73 Bn | 696.04 Mn | -85.11 Mn |
| 7 | Illumina | 30.03 Bn | 28.86 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.67 Bn | 28.62 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Quest Diagnostics | 26.16 Bn | 25.54 Bn | 1.03 Bn | 324.00 Mn |
| 10 | Myriad Genetics | 294.69 Mn | 170.29 Mn | 137.60 Mn | -34.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34.10 Mn |
| Dec 31, 2025 | -7.90 Mn |
| Sep 30, 2025 | -27.40 Mn |
| Jun 30, 2025 | -330.50 Mn |
| Mar 31, 2025 | -100,000.00 |
| Dec 31, 2024 | -42.50 Mn |
| Sep 30, 2024 | -22.10 Mn |
| Jun 30, 2024 | -36.70 Mn |
| Mar 31, 2024 | -26.00 Mn |
| Dec 31, 2023 | -31.20 Mn |
| Sep 30, 2023 | -61.30 Mn |
| Jun 30, 2023 | -116.10 Mn |
| Mar 31, 2023 | -54.70 Mn |
| Dec 31, 2022 | -42.30 Mn |
| Sep 30, 2022 | -35.10 Mn |
| Jun 30, 2022 | -14.10 Mn |
| Mar 31, 2022 | -20.50 Mn |
| Dec 31, 2021 | -7.60 Mn |
| Sep 30, 2021 | 24.60 Mn |
| Jun 30, 2021 | -4.70 Mn |